Supermodel Janice Dickinson Teams Up with Blue Horizon Stem Cells for Launch of Special Skin Serum Blue Horizon Stem Cells unveiled their new Special Skin Serum on September 26 at Fashion Week in Paris, France.
NEW YORK, Nov. 8, 2013 /PRNewswire/ -- Supermodel Janice Dickinson and Blue Horizon Stem Cells have announced the launch of a new skin care product, Special Skin Serum. Initial shipments of the serum, which have recently been made available for worldwide pre-order on www.bluehorizonskincare.com, have been set for the first week of December.
"My skin is just amazing," said Dickinson, self-professed supermodel pioneer. "My face, my legs, my hands and my feet...everything got so smooth. My life has improved tremendously."
While Special Skin Serum does not contain actual stem cells, it is derived from the same proprietary process used to treat patients in Blue Horizon Stem Cells' worldwide research facilities. The company's team of health care experts and scientists say that this particular serum stands to revolutionalize the skin care industry, as it is one of the most potent anti-aging cocktails on the international market.
"The serum not only refreshes peptides and boosts elastin; it also delivers key protein-activating cytokines, short-and-long-chained hyaluronic acids and EGF growth-factors to the skin," said Dr. Brian Mehling, founder of Blue Horizon Stem Cells.
Such progress is no stranger to controversy, however. Companies involved in stem cell research have increasingly come under fire in recent years amid doubts of ethical legitimacy.
"We do not and will not ever engage in embryonic or fetal stem cell research," said Mehling. "Special Skin Serum is a potent anti-aging innovation, but it has been safely formulated in conjunction with years of non-embryonic stem cell research."
Blue Horizon Stem Cells, a subsidiary of Blue Horizon International, provides stem cell therapy and research to patients worldwide; and has safely and efficiently performed over 2,000 documented procedures. The program is associated with the Stem Cell Centre, Hongqiao Brain Hospital, China's Wuhan University School of Basic Medical Science and Slovakia's Medissimo Hospital. For more information visit www.bluehorizonstemcells.com.
SOURCE Blue Horizon International